Bergtold et al., 2014)
Jednak ze wzgldu na potencjalne skutki uboczne i brak penej rejestracji tych produktw jako lekw, uytkownicy powinni zachowa szczegln odpowiedzialno i regularnie monitorowa reakcje swojego organizmu
*Based on comparisons to similar programs offering GLP-1 weight loss treatments compared to standard market pricing
According to the Novo Nordisk's website, minor side-effects include nausea, vomiting, diarrhea, constipation and abdominal pain
If approved for weight management, general eligibility criteria would typically include: Body Mass Index (BMI) 30 kg/m (obesity), or BMI 27 kg/m (overweight) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease Age 18 years or older Previous unsuccessful attempts at weight loss through diet and exercise alone Commitment to a comprehensive weight management programme including dietary modification and increased physical activity NICE guidance may specify lower BMI thresholds for certain ethnic groups (particularly those of South Asian origin) who are at increased risk of complications at lower BMI levels
